Skip to content

Comparison of 2 Body Oil in Prevention of Striae Gravidarum

The Effect of Elasticity Belly® Oil and Clarins® Tonic Body Treatment Oil in Prevention of Striae Gravidarum: A Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02879045
Enrollment
50
Registered
2016-08-25
Start date
2016-08-31
Completion date
2017-08-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention Harmful Effects

Brief summary

The effect of elasticity Belly® oil and Clarins® Tonic Body Treatment Oil in prevention of striae gravidarum: A randomized controlled clinical trial.

Detailed description

Objective: To compare the clinical efficacy of Elasticity Belly® oil and Clarins® Tonic Body Treatment Oil on the occurrence and severity of striae gravidarum. Design: Parallel randomized controlled clinical trial. Setting: Gynaecology and Obstetrics department, Shanghai Changning Maternity and Infant Health Hospital, China Interventions: We will enroll about 50 Nulliparous women randomly, who are in their second trimester of pregnancy. Volunteer's abdomen skin are divided into two parts through medioventral line, half of the abdomen skin will receive the elasticity Belly® oil to prevent striae gravidarum, and the other side will use the Clarins® Tonic Body Treatment Oil. Volunteers apply these two kinds of oil daily until gestational age of 38-40 weeks. We'll take abdomen pictures before and after interventions, and the occurrence of striae on abdominal skin and its severity will be evaluated as our primary outcome of the study.

Interventions

OTHERElasticity Belly® oil

We will enroll about 50 Nulliparous women randomly, who are in their second trimester of pregnancy. We divide each of the volunteer's abdomen skin into two parts through medioventral line, one of the abdomen skin will receive the elasticity Belly® oil to prevent striae gravidarum, and the other side will use the Clarins® oil. Volunteers apply these two kinds of oil daily until birth. We'll take abdomen pictures before and after interventions, and the occurrence of striae on abdominal skin and its severity will be evaluated as our primary end point of the study.

Sponsors

Tongji University
CollaboratorOTHER
Shanghai Changning Maternity & Infant Health Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* nulliparous females * gestational age of 14-20 weeks * 20 to 35 years old * body mass index (BMI) from 18.5 to 25 * Clear consciousness, intelligence is normal,stable vital signs * Voluntary participation, and sign the informed consent

Exclusion criteria

* allergy to skin care products * twin pregnancies or polypregnancies * polyhydramnios * miscarriages * development of a skin disease * corticosteroid usage * application of any other cream on the abdominal skin * did not received allocated intervention * drop out or lost to follow-up

Design outcomes

Primary

MeasureTime frameDescription
occurrence and severity of striae gravidarumsecond trimester to term birthvolunteer's abdomen skin are divided into two parts through medioventral line, half of the abdomen skin will receive the elasticity Belly® oil , and the other side will use the Clarins® Tonic Body Treatment Oil. Volunteers apply these two kinds of oil daily until birth. We'll take abdomen pictures before and after interventions, and the occurrence of striae on abdominal skin and its severity will be evaluated as our primary end point of the study.

Countries

China

Contacts

Primary ContactDong Zhao, M.D.
877088319@qq.com13636446556
Backup ContactShating Lei, PhD
leishating@163.com18801930362

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026